Biontech Se
Clinical trials sponsored by Biontech Se, explained in plain language.
-
BioNTech tests new cancer drug targeting specific tumor marker
Disease control TerminatedThis early-phase study tested a new drug called BNT142 in people with advanced solid tumors that have a specific marker called CLDN6. The main goals were to find a safe dose and see if the drug showed any signs of helping shrink tumors. The trial included patients with cancers li…
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Early-Stage pancreatic cancer drug trial halted after just one patient
Disease control TerminatedThis study aimed to see if adding an experimental drug called BNT321 to standard chemotherapy (mFOLFIRINOX) could better prevent pancreatic cancer from returning after surgery. It was designed for patients who had their tumor completely removed. The sponsor stopped the trial earl…
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Mar 06, 2026 15:45 UTC